The Indianapolis Colts (4-5) saw an embarrassing performance from their offense in a 21-13 defeat by the Minnesota Vikings (6 ...

Viking aims to compete against market giants Eli Lilly and Novo Nordisk in the billion-dollar weight loss drug market. The ...

The Viking offense inflicted plenty of second-half damage on the 17th-ranked Dickinson State Bluehawks Saturday. But the ...

Sam Darnold made three errors that could have ruined the night. He’ll need to show better poise if any playoff goals are to ...

Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug showing ...

Following the Minnesota Vikings' 21-13 victory over the Indianapolis Colts on Sunday night, fans criticized veteran ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here's how Americans ...

The Vikings have been mostly healthy across the roster this season but against the Rams disaster struck. At the end of the ...

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 study ...

Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Viking Therapeutics' highly anticipated readout of its oral anti-obesity pill showed a placebo-adjusted weight loss of 6.8% after four weeks, sticking the biotech near the front of ...

Oral GLP-1 drug in study led to average weight loss of 8.2% in a month at a 100 mg dose Viking Therapeutics Inc. cheered analysts Monday after the biotech posted data on its oral weight-loss drug ...